Clinical trials serve a vital role in the development and advancement of life-saving medicines for the treatment of cancer. Without clinical trials, there is no progress. Without progress, more than 22,000 people worldwide will continue to die of cancer every single day. Unfortunately, there is still a stigma that clinical trials are only an experimental option for patients that are nearly dead. This couldn’t be further from the truth. Today’s clinical trials are not only safe, but offer patients with access to tomorrow’s medicines, today.
In this presentation, Matt Ellefson, a seven year survivor of advanced lung cancer, discusses his cancer care journey which includes two clinical trials. Matt discusses why he feels clinical trials are underutilized today and why the makers of life-saving medicines have difficulty meeting clinical trial participation goals.